3-Methyl-8-Quinolinesulphonyl Chloride CAS 74863-82-4 Argatroban Intermediate Factory 98.0%
Mea Hoʻolako Mea Hana Argatroban Nā Kūwaena Pili:
Ethyl (2R,4R)-4-Methyl-2-Piperidinecarboxylate CAS 74892-82-3
N-Nitro-1,2,3,4-tetradehydro Argatroban Ethyl Ester CAS 74874-09-2
3-Methyl-8-Quinolinesulphonyl Chloride CAS 74863-82-4
Argatroban Monohydrate CAS 141396-28-3
Argatroban Anhydrous CAS 74863-84-6
Inoa Kimia | 3-Methyl-8-Quinolinesulphonyl Chloride |
Nā huaʻōlelo like | 3-Methylquinoline-8-Sulfonyl Chloride |
Helu CAS | 74863-82-4 |
Helu CAT | RF-PI269 |
Kūlana Kūʻai | Ma ka waihona, ʻoi aku ka nui o ka hana a hiki i nā tona |
ʻĀpana Molekala | C10H8ClNO2S |
Kaumaha Molecular | 241.69 |
ʻO ka mānoanoa | 1.4±0.1 g/cm3 |
Hōʻike Hōʻike | 1.63 |
Ka hoʻoheheʻe | Hiki ke hoʻoheheʻe ʻia i loko o Chloroform |
Kūlana Hoʻouna | Hoʻouna ʻia ma lalo o ka wela ambient |
Brand | ʻO Ruifu Chemical |
'ikamu | Nā kikoʻī |
Ka nana aku | Pauda Crystalline Keʻokeʻo |
Maʻemaʻe / Kaʻina Hanana | >98.0% (HPLC) |
Lae hehee | 162.0~163.0 ℃ |
Nalo ma ka maloo | <0.50% |
3-Methylquinoline-8-Sulfonic Acid | <1.00% |
Huina paumaele | <2.00% |
Infrared Spectrum | Kūlike i ka hoʻolālā |
NMR | Kūlike i ka hoʻolālā |
Kūlana hoʻāʻo | ʻOihana Kūlana |
Hoʻohana | Kūwaena o Argatroban (CAS 74863-84-6) |
Pūʻolo: ʻOmole, ʻeke ʻeke Aluminum, 25kg / pahu pahu pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.
Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;Pale mai ka māmā a me ka makū
ʻO Shanghai Ruifu Chemical Co., Ltd. ka mea hana nui a me ka mea hoʻolako o 3-Methyl-8-Quinolinesulphonyl Chloride (CAS: 74863-82-4) me ke ʻano kiʻekiʻe, hoʻohana nui ʻia i ka synthesis organik, synthesis o nā intermediates pharmaceutical a me Active Pharmaceutical Ingredient (API) synthesis.ʻO iahe mea waena maʻamau i ka synthesis o Argatroban (CAS: 74863-84-6) a i ʻole Argatroban Monohydrate (CAS 141396-28-3).
ʻO Argatroban (CAS: 74863-84-6) kahi anticoagulant kahi mole liʻiliʻi liʻiliʻi pololei thrombin inhibitor.I ka makahiki 2000, ua laikini ʻia ka argatroban e ka Food and Drug Administration (FDA) no ka prophylaxis a i ʻole ka mālama ʻana i ka thrombosis i nā maʻi me ka thrombocytopenia (HIT).I ka makahiki 2002, ua ʻae ʻia no ka hoʻohana ʻana i ka wā o ka hoʻoponopono coronary percutaneous i nā poʻe maʻi i loaʻa iā HIT a i ʻole ka pilikia no ka hoʻomohala ʻana.Ma 2012, ua ʻae ʻia e ka MHRA ma UK no ka anticoagulation i nā maʻi me ka heparin-induced thrombocytopenia Type II (HIT) e koi ana i ka antithrombotic therapy parenteral.